NCT00075998View on ClinicalTrials.gov

The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)

PHASE3TerminatedINTERVENTIONAL
Enrollment

826

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

May 31, 2007

Conditions
Idiopathic Pulmonary FibrosisLung DiseasePulmonary Fibrosis
Interventions
DRUG

"Interferon gamma-1b (Actimmune)"

200 mcg, SQ, 3x per week

Trial Locations (1)

94005

InterMune, Inc., Brisbane

Sponsors

Lead Sponsor

InterMune
All Listed Sponsors
lead

InterMune

INDUSTRY

NCT00075998 - The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) | Biotech Hunter | Biotech Hunter